Olaparib plus bevacizumab as a first-line maintenance treatment for patients with advanced ovarian cancer by molecular status: an updated PAOLA-1 based cost-effectiveness analysis
Article in Journal of Gynecologic Oncology (January 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in Journal of Gynecologic Oncology (January 2024)
Article in Biomedical Research and Therapy (December 2023)
Article in Cell Reports (October 2023)